Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
Schultz, Michael K.1; Shutt, Damon C.2; Weiland, Nicholas A.2; White, Neja2; Schafer, Blanca2; Martin, Molly E.2; Boles Ponto, Laura L.1; Walsh, Susan3; O'Dorisio, Thomas M.4; O'Dorisio, Sue2
University of Iowa, Carver College of Medicine, Iowa City, IA, 1Department of Radiology; 2Department of Pediatrics; 3Small Animal Imaging Core, Holden Comprehensive Cancer Center; 4Department of Internal Medicine.
Gallium-68 (68Ga) labeled analogs of somatostatin (sst) have been demonstrated to be effective for imaging NETs by positron emission tomography (PET) in European clinical studies. These radiopharmaceuticals are more reliable (and prepared more conveniently) than fluorine-18 (18F) labeled glucose (18F-FDG) and dihydroxyphenylalanine (18F-DOPA); with superior image quality/sensitivity compared to indium-111 single-photon-emission computed tomography (SPECT). 68Ga-sst analogs target upregulation of sst receptor subtype-2 (sst2) in NETs. However, upregulated sst2 in NET is not ubiquitous and alternative-receptor targets (e.g., G-protein coupled receptors) are needed. We examined [68Ga]-labeled analogs of sst and neuropeptide-Y (NPY) for imaging xenograft NETs in rats.
Cells (BON, SKNBE, SHSY5Y) were cultured by standard techniques. Sst analog tyr3-octreotide (TOC) and NPY derivative YPSKxRHYINLITRQRY (NxPY; targeting NPY receptor subtype 2; x = hexanoic acid) were conjugated to chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) by standard methods. Radiolabeling was performed at pH 3.5 (100°C, 10-20 minutes). Competitive binding assays established receptor specificity. Tumors were induced by subcutaneous flank injection of cells in nude rats (∼4 weeks). Radiochemical purity (RP) and specific activity (SA) were monitored by radioHPLC. Imaging was performed using a Phillips Mosaic microPET.
Binding assays demonstrate receptor specific binding with low IC50's (nM range) for [68Ga]-DOTATOC and [68Ga]-DOTANxPY. Western blots confirmed receptor expression. Dynamic PET imaging of [68Ga]-DOTATOC (15.6 MBq) revealed SKNBE2 tumor:background accumulated to a constant value of 7 (120 min. PI), while BON tumor activity increased for approximately 60 minutes and then decreased to a final value of 3.6 (120 min. PI). Static imaging of [68Ga]-DOTANxPY (11.6 MBq) revealed a tumor(SHSY5Y):background of 2 at 60 min. PI. Radiolabeling results:
These results prepare us to move forward with [68Ga]-DOTATOC for early phase PET imaging trials of NETs. [68Ga]-DOTANPY is a promising radiopharmaceutical.
© 2010 Lippincott Williams & Wilkins, Inc.
Colleague's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at Pancreas.
Send a copy to your email
Your message has been successfully sent to your colleague.
Some error has occurred while processing your request. Please try after some time.
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Login with your LWW Journals username and password.
Username or Email:
Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.
Link to reset your password has been sent to specified email address.
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Save my selection
Article Level Metrics